Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel
Gyeoung-Jin Kang, … , Hong Liu, Samuel C. Dudley Jr.
Gyeoung-Jin Kang, … , Hong Liu, Samuel C. Dudley Jr.
Published October 27, 2020
Citation Information: JCI Insight. 2020;5(23):e140759. https://doi.org/10.1172/jci.insight.140759.
View: Text | PDF
Research Article Cardiology

MIR448 antagomir reduces arrhythmic risk after myocardial infarction by upregulating the cardiac sodium channel

  • Text
  • PDF
Abstract

Cardiac ischemia is associated with arrhythmias; however, effective therapies are currently limited. The cardiac voltage-gated sodium channel α subunit (SCN5A), encoding the Nav1.5 current, plays a key role in the cardiac electrical conduction and arrhythmic risk. Here, we show that hypoxia reduces Nav1.5 through effects on a miR, miR-448. miR-448 expression is increased in ischemic cardiomyopathy. miR-448 has a conserved binding site in 3′-UTR of SCN5A. miR-448 binding to this site suppressed SCN5A expression and sodium currents. Hypoxia-induced HIF-1α and NF-κB were major transcriptional regulators for MIR448. Moreover, hypoxia relieved MIR448 transcriptional suppression by RE1 silencing transcription factor. Therefore, miR-448 inhibition reduced arrhythmic risk after myocardial infarction. Here, we show that ischemia drove miR-448 expression, reduced Nav1.5 current, and increased arrhythmic risk. Arrhythmic risk was improved by preventing Nav1.5 downregulation, suggesting a new approach to antiarrhythmic therapy.

Authors

Gyeoung-Jin Kang, An Xie, Hong Liu, Samuel C. Dudley Jr.

×

Figure 8

Blocking of miR-448 improves Nav1.5 levels and arrhythmic risk after MI.

Options: View larger image (or click on image) Download as PowerPoint
Blocking of miR-448 improves Nav1.5 levels and arrhythmic risk after MI....
(A) Effect of miR-448 antagonism on cardiac SCN5A mRNA level after MI. The heart tissues were collected from MI+Con or MI+448-Spo. (B and C) Effect of miR-448 antagonism on protein level of cardiac Nav1.5 after MI. The heart tissues were collected from MI+Con or MI+448-Spo. IHC localization of Nav1.5 antigen done using formalin-fixed, paraffin-embedded heart tissues. Tissue sections were incubated with Nav1.5 antibody. Positively stained cells were evaluated using Image J analysis. (D) The number of mice in each group with or without ventricular tachycardia (VT). Data are represented as the mean + SD or mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 (when compared between indicated groups by Student’s t test or 1-way ANOVA with Sidak’s multiple-comparison test).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts